Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Global Forecast to 2030

Publisher Name :
Date: 21-Jun-2022
No. of pages: 611

The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.

Liquid biopsy tests are executed to understand the molecular aspects of cancer across the healthcare and research settings, such as hospitals, physicians, pathological and research laboratories. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.

Impact of COVID-19 on Global Liquid Biopsy Market

The COVID–19 outbreak has become a global stress test. As the number of people infected with the virus continues to rise around the world, uncertainties about global economic growth increases. The COVID–19 disease has infected around 532 Million people worldwide. Globally the death toll has reached 6,311,594 according to the latest statistics from the Worldometers (as of May 31, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The reactions to the COVID–19 pandemic and its effects on societies and economies around the world cannot be understated. The COVID–19 global pandemic has restricted the growth rate of the liquid biopsy market to some extent during 2020-2021. However, many countries have taken strict measures to combat the coronavirus, such as mass vaccination program, social distancing, use of masks, etc. Hence, we expect that the physicians/surgeons will see an increase in influx of patients, hence driving the liquid biopsy market growth.

Recent Developments


  • In March 2022, the Japanese Ministry of Health, Labour and Welfare granted regulatory approval of Guardant360 CDx, a liquid biopsy test for tumor mutation profiling, also known as comprehensive genomic profiling, in patients with advanced solid tumors.

  • In February 2022, Labcorp, a leading global life sciences company, closed its acquisition of Personal Genome Diagnostics Inc., a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.

  • In July 2021, Biocept, Inc. was awarded a South Korean Patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using real-time PCR and associated analysis methods.

  • In March 2021, Lucence announced a partnership with Waseda University in Japan to develop a novel high-speed liquid biopsy laser-based imaging platform for early cancer detection.

  • In February 2021, Guardant Health, Inc. announced the availability of Guardant Reveal, the first blood-only liquid biopsy test for the detection of residual and recurrent disease from a simple blood draw.


Global Liquid Biopsy Market & Forecast - by Circulating Biomarker


  • Based on circulating biomarkers, in 2021, the circulating tumor cells (CTCs) segment captured largest share of the liquid biopsy market.

  • The circulating tumor DNA (ctDNA) is the 2nd largest segment of the liquid biopsy market.

  • The extracellular vesicles (EVs) segment is the fastest growing segment during the forecast period.


Global Liquid Biopsy Market & Forecast - by Products


  • On the basis of product, the Kits and Consumables segment is expected to account for largest share of the liquid biopsy market.

  • The instruments segment is likely to witness highest growth in the global liquid biopsy market.

  • The services segment captured least share of the liquid biopsy market.


Global Liquid Biopsy Market & Forecast - by Application


  • The global liquid biopsy market, by application, is being dominated by oncology application.

  • Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.

  • The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.


Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application


  • On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecast period.

  • Treatment monitoring captured second highest share of the liquid biopsy market in 2021, being followed by the early cancer screening application.

  • Recurrence monitoring captured least share of the liquid biopsy market.


Global Liquid Biopsy Market & Forecast - by End User


  • In 2021, Reference laboratories form the largest and fastest-growing end-user segment of the liquid biopsy market.

  • Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2021, being followed by Academic and Research Centers.


Global Liquid Biopsy Market & Forecast - by Sample Type


  • Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.

  • The urine sample segment is anticipated to witness noticeable growth throughout the forecast period.


Liquid Biopsy Market & Forecast - Regional Analysis


  • North America accounted for largest share of the global liquid biopsy market in 2021.

  • In 2021, Europe captured second largest share of the global liquid biopsy market.

  • In Europe, Germany and France are the leading market for liquid biopsy.

  • Asia pacific is the fastest growing market for liquid biopsy.

  • In Asia Pacific, Japan and China are the leading market for liquid biopsy.

  • Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.


Report titled “Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Global Forecast to 2030” provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.

This 611 Page report with 118 Figures and 7 Tables has been analyzed from 16 viewpoints:


  • 1. Global Liquid Biopsy Market & Forecast (2016 - 2030)

  • 2. Impact of COVID-19 on Global Liquid Biopsy Market

  • 3. Global Liquid Biopsy Market Share & Forecast (2016 - 2030)

  • 4. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2016 - 2030)

  • 5. Global Liquid Biopsy Market & Forecast - by Product (2016 - 2030)

  • 6. Global Liquid Biopsy Market & Forecast - by Application (2016 - 2030)

  • 7. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2016 - 2030)

  • 8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2016 - 2030)

  • 9. Global Liquid Biopsy Market & Forecast - by End User (2016 - 2030)

  • 10. Global Liquid Biopsy Market & Forecast - by Sample Type (2016 - 2030)

  • 11. Liquid Biopsy Market & Forecast - Regional Analysis (2016 - 2030)

  • 12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2016 - 2030)

  • 13. Liquid Biopsy Initiatives

  • 14. Liquid Biopsy Companies Financing Details

  • 15. 35 Company Profiles – Recent Developments / Initiatives, Major Deals

  • 16. Global Liquid Biopsy Market - Driving Factors & Challenges


Global Liquid Biopsy Market & Forecast - by Circulating Biomarker


  • Circulating Tumor Cells (CTCs)

  • Circulating Tumor DNA (ctDNA)

  • Cell-Free DNA (cfDNA)

  • Extracellular Vesicles (EVs)

  • Other Circulating Biomarkers


Global Liquid Biopsy Market & Forecast - by Product


  • Kits and Consumables

  • Instruments

  • Services


Global Liquid Biopsy Market & Forecast - by Application


  • Oncology Application

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Prostate Cancer

    • Gastrointestinal Cancer

    • Leukaemia

    • Others



  • Non-Cancer Application


Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application


  • Therapy Selection

  • Treatment Monitoring

  • Early Cancer Screening

  • Recurrence Monitoring


Global Liquid Biopsy Market & Forecast - by End User


  • Reference Laboratories

  • Hospitals and Physician Laboratories

  • Academic and Research Centers

  • Other End Users


Global Liquid Biopsy Market & Forecast - by Sample Type


  • Blood Sample

  • Urine Sample

  • Other Fluids Sample


Liquid Biopsy Market & Forecast - Regional Analysis


  • North America

    • United States

    • Canada



  • Asia Pacific

    • South Korea

    • Japan

    • China

    • India

    • Australia

    • Rest of Asia Pacific



  • Europe

    • Germany

    • France

    • United Kingdom

    • Italy

    • Spain

    • Rest of Europe



  • Middle East & Africa

    • UAE

    • Saudi Arabia

    • Egypt

    • Rest of Middle East & Africa



  • Latin America


Liquid Biopsy Market - Company Profiles, Recent Developments / Initiatives, Major Deals


  • 1. Personal Genome Diagnostics

  • 2. Guardant Health, Inc.

  • 3. Pathway Genomics (Now OME CARE)

  • 4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

  • 5. Cardiff Oncology (Previously Trovagene, Inc.)

  • 6. LungLife AI (Formerly Cynvenio Biosystems, Inc.)

  • 7. Biocept, Inc.

  • 8. ANGLE plc

  • 9. MDxHealth

  • 10. Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)

  • 11. Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)

  • 12. Foundation Medicine, Inc

  • 13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

  • 14. Genomic Health (Now Part of Exact Sciences Corp)

  • 15. Myriad Genetics, Inc

  • 16. Thermo Fisher Scientific, Inc

  • 17. QIAGEN NV

  • 18. Bio-Rad Laboratories, Inc

  • 19. Menarini-Silicon Biosystems

  • 20. GRAIL

  • 21. NeoGenomics, Inc.

  • 22. DiaCarta, Inc.

  • 23. OncoCell MDx (Now Immunis.AI)

  • 24. C2i Genomics

  • 25. Biodesix

  • 26. Freenome

  • 27. Inivata

  • 28. CellMax Life

  • 29. Rarecyte Inc.

  • 30. Saga Diagnostics

  • 31. Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)

  • 32. Lucence Diagnostics Pte Ltd

  • 33. Karius, Inc.

  • 34. Clinical Genomics Technologies Pty Ltd (CG)

  • 35. Elypta


Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Global Forecast to 2030

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market & Forecast (2016 - 2030)

4. Global Liquid Biopsy Market Share & Forecast (2016 - 2030)
4.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
4.2 Global Liquid Biopsy Market Share & Forecast - by Product
4.3 Global Liquid Biopsy Market Share & Forecast - by Application
4.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
4.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
4.6 Global Liquid Biopsy Market Share & Forecast - by End User
4.7 Global Liquid Biopsy Market Share & Forecast - by Sample Type
4.8 Liquid Biopsy Market Share & Forecast - Regional Analysis
4.9 Liquid Biopsy Market Share & Forecast - Country Wise Analysis

5. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2016 - 2030)
5.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
5.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
5.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
5.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
5.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast

6. Global Liquid Biopsy Market & Forecast - by Product (2016 - 2030)
6.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
6.2 Global Liquid Biopsy - Instruments Market & Forecast
6.3 Global Liquid Biopsy - Services Market & Forecast

7. Global Liquid Biopsy Market & Forecast - by Application (2016 - 2030)
7.1 Global Liquid Biopsy - Oncology Application Market & Forecast
7.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
7.2.1 Lung Cancer Liquid Biopsy Market & Forecast
7.2.2 Breast Cancer Liquid Biopsy Market & Forecast
7.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
7.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
7.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
7.2.6 Leukaemia Liquid Biopsy Market & Forecast
7.2.7 Others Liquid Biopsy Market & Forecast
7.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2016 - 2030)
8.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
8.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
8.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
8.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast

9. Global Liquid Biopsy Market & Forecast - by End User (2016 - 2030)
9.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
9.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
9.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
9.4 Global Liquid Biopsy - Other End Users Market & Forecast

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2016 - 2030)
10.1 Global Liquid Biopsy - Blood Sample Market & Forecast
10.2 Global Liquid Biopsy - Urine Sample Market & Forecast
10.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast

11. Liquid Biopsy Market & Forecast - Regional Analysis (2016 - 2030)
11.1 North America Liquid Biopsy Market & Forecast
11.2 Asia Pacific Liquid Biopsy Market & Forecast
11.3 Europe Liquid Biopsy Market & Forecast
11.4 Latin America Liquid Biopsy Market & Forecast
11.5 Middle East & Africa Liquid Biopsy Market & Forecast

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2016 - 2030)
12.1 North America Liquid Biopsy Market & Forecast
12.1.1 United States Liquid Biopsy Market & Forecast
12.1.2 Canada Liquid Biopsy Market & Forecast
12.2 Asia Pacific Liquid Biopsy Market & Forecast
12.2.1 South Korea Liquid Biopsy Market & Forecast
12.2.2 Japan Liquid Biopsy Market & Forecast
12.2.3 China Liquid Biopsy Market & Forecast
12.2.4 India Liquid Biopsy Market & Forecast
12.2.5 Australia Liquid Biopsy Market & Forecast
12.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast
12.3 Europe Liquid Biopsy Market & Forecast
12.3.1 Germany Liquid Biopsy Market & Forecast
12.3.2 France Liquid Biopsy Market & Forecast
12.3.3 United Kingdom Liquid Biopsy Market & Forecast
12.3.4 Italy Liquid Biopsy Market & Forecast
12.3.5 Spain Liquid Biopsy Market & Forecast
12.3.6 Rest of Europe Liquid Biopsy Market & Forecast
12.4 Middle East & Africa Liquid Biopsy Market & Forecast
12.4.1 UAE Liquid Biopsy Market & Forecast
12.4.2 Saudi Arabia Liquid Biopsy Market & Forecast
12.4.3 Egypt Liquid Biopsy Market & Forecast
12.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast
12.5 Latin America Liquid Biopsy Market & Forecast

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. Company Profiles
15.1 Personal Genome Diagnostics (Acquired by Labcorp)
15.1.1 Company Overview
15.1.2 Recent Developments / Initiatives
15.2 Guardant Health, Inc.
15.2.1 Company Overview
15.2.2 Recent Developments / Initiatives
15.3 Pathway Genomics (Now OME CARE)
15.3.1 Company Overview
15.3.2 Recent Developments / Initiatives
15.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
15.4.1 Company Overview
15.4.2 Recent Developments / Initiatives
15.5 Cardiff Oncology (Previously Trovagene, Inc.)
15.5.1 Company Overview
15.5.2 Recent Developments / Initiatives
15.6 LungLife AI (Formerly Cynvenio Biosystems, Inc.)
15.6.1 Company Overview
15.6.2 Recent Developments / Initiatives
15.7 Biocept, Inc.
15.7.1 Company Overview
15.7.2 Recent Developments / Initiatives
15.8 ANGLE plc
15.8.1 Company Overview
15.8.2 Recent Developments / Initiatives
15.9 MDxHealth
15.9.1 Company Overview
15.9.2 Recent Developments / Initiatives
15.10 Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)
15.10.1 Company Overview
15.10.2 Recent Developments / Initiatives
15.11 Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
15.11.1 Company Overview
15.11.2 Recent Developments / Initiatives
15.12 Foundation Medicine, Inc.
15.12.1 Company Overview
15.12.2 Recent Developments / Initiatives
15.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
15.13.1 Company Overview
15.13.2 Recent Developments / Initiatives
15.14 Genomic Health (Now Part of Exact Sciences Corp)
15.14.1 Company Overview
15.14.2 Recent Developments / Initiatives
15.15 Myriad Genetics, Inc.
15.15.1 Company Overview
15.15.2 Recent Developments / Initiatives
15.16 Thermo Fisher Scientific, Inc.
15.16.1 Company Overview
15.16.2 Recent Developments / Initiatives
15.17 QIAGEN NV
15.17.1 Company Overview
15.17.2 Recent Developments / Initiatives
15.18 Bio-Rad Laboratories, Inc.
15.18.1 Company Overview
15.18.2 Recent Developments / Initiatives
15.19 Menarini-Silicon Biosystems
15.19.1 Company Overview
15.19.2 Recent Developments / Initiatives
15.20 GRAIL
15.20.1 Company Overview
15.20.2 Recent Developments / Initiatives
15.21 NeoGenomics, Inc.
15.21.1 Company Overview
15.21.2 Recent Developments / Initiatives
15.22 DiaCarta, Inc.
15.22.1 Company Overview
15.22.2 Recent Developments / Initiatives
15.23 OncoCell MDx (Now Immunis.AI)
15.23.1 Company Overview
15.23.2 Recent Developments / Initiatives
15.24 C2i Genomics
15.24.1 Company Overview
15.24.2 Recent Developments / Initiatives
15.25 Biodesix
15.25.1 Company Overview
15.25.2 Recent Developments / Initiatives
15.26 Freenome
15.26.1 Company Overview
15.26.2 Recent Developments / Initiatives
15.27 Inivata
15.27.1 Company Overview
15.27.2 Recent Developments / Initiatives
15.28 CellMax Life
15.28.1 Company Overview
15.28.2 Recent Developments / Initiatives
15.29 Rarecyte Inc.
15.29.1 Company Overview
15.29.2 Recent Developments / Initiatives
15.30 Saga Diagnostics
15.30.1 Company Overview
15.30.2 Recent Developments / Initiatives
15.31 Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)
15.31.1 Company Overview
15.31.2 Recent Developments / Initiatives
15.32 Lucence Diagnostics Pte Ltd
15.32.1 Company Overview
15.32.2 Recent Developments / Initiatives
15.33 Karius, Inc.
15.33.1 Company Overview
15.33.2 Recent Developments / Initiatives
15.34 Clinical Genomics Technologies Pty Ltd (CG)
15.34.1 Company Overview
15.34.2 Recent Developments / Initiatives
15.35 Elypta
15.35.1 Company Overview
15.35.2 Recent Developments / Initiatives

16. Global Liquid Biopsy Market - Driving Factors
16.1 Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market
16.2 Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice
16.3 Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market
16.4 New Liquid Biopsy Product Launches to Fuel Market Revenues
16.5 Government Funds for Refining Cancer Detection Drives the Liquid Biopsy Market Growth
16.6 Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market

17. Global Liquid Biopsy Market - Challenges
17.1 Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market
17.2 Liquid Biopsy Clinical Utility Challenges
17.3 Unclear Regulations on Laboratory Developed Tests (LDT) for Liquid Biopsy

List of Figures:

Figure 3-1: Global - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 3-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 4-1: By Circulating Biomarker - Liquid Biopsy Market Share (Percent), 2016 - 2021
Figure 4-2: By Circulating Biomarker - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
Figure 4-3: By Product - Liquid Biopsy Market Share (Percent), 2016 - 2021
Figure 4-4: By Product - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
Figure 4-5: By Application - Liquid Biopsy Market Share (Percent), 2016 - 2021
Figure 4-6: By Application - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
Figure 4-7: By Clinical Application - Liquid Biopsy Oncology Market Share (Percent), 2016 - 2021
Figure 4-8: By Clinical Application - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2022 - 2030
Figure 4-9: By End User - Liquid Biopsy Market Share (Percent), 2016 - 2021
Figure 4-10: By End User - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
Figure 4-11: By Sample Type - Liquid Biopsy Market Share (Percent), 2016 - 2021
Figure 4-12: By Sample Type - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
Figure 5-1: Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market (Million US$), 2016 - 2021
Figure 5-2: Global Liquid Biopsy - Forecast for Circulating Tumor Cells (CTCs) Market (Million US$), 2022 - 2030
Figure 5-3: Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market (Million US$), 2016 - 2021
Figure 5-4: Global Liquid Biopsy - Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2022 - 2030
Figure 5-5: Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market (Million US$), 2016 - 2021
Figure 5-6: Global Liquid Biopsy - Forecast for Cell-Free DNA (cfDNA) Market (Million US$), 2022 - 2030
Figure 5-7: Global Liquid Biopsy - Extracellular Vesicles (EVs) Market (Million US$), 2016 - 2021
Figure 5-8: Global Liquid Biopsy - Forecast for Extracellular Vesicles (EVs) Market (Million US$), 2022 - 2030
Figure 5-9: Global Liquid Biopsy - Other Circulating Biomarkers Market (Million US$), 2016 - 2021
Figure 5-10: Global Liquid Biopsy - Forecast for Other Circulating Biomarkers Market (Million US$), 2022 - 2030
Figure 6-1: Global Liquid Biopsy - Kits and Consumables Market (Million US$), 2016 - 2021
Figure 6-2: Global Liquid Biopsy - Forecast for Kits and Consumables Market (Million US$), 2022 - 2030
Figure 6-3: Global Liquid Biopsy - Instruments Market (Million US$), 2016 - 2021
Figure 6-4: Global Liquid Biopsy - Forecast for Instruments Market (Million US$), 2022 - 2030
Figure 6-5: Global Liquid Biopsy - Services Market (Million US$), 2016 - 2021
Figure 6-6: Global Liquid Biopsy - Forecast for Services Market (Million US$), 2022 - 2030
Figure 7-1: Global Liquid Biopsy - Oncology Application Market (Million US$), 2016 - 2021
Figure 7-2: Global Liquid Biopsy - Forecast for Oncology Application Market (Million US$), 2022 - 2030
Figure 7-3: Global - Lung Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 7-4: Global - Forecast for Lung Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 7-5: Global - Breast Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 7-6: Global - Forecast for Breast Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 7-7: Global - Colorectal Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 7-8: Global - Forecast for Colorectal Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 7-9: Global - Prostate Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 7-10: Global - Forecast for Prostate Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 7-11: Global - Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 7-12: Global - Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 7-13: Global - Leukaemia Cancer Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 7-14: Global - Forecast for Leukaemia Cancer Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 7-15: Global - Others Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 7-16: Global - Forecast for Others Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 7-17: Global Liquid Biopsy - Non-Cancer Application Market (Million US$), 2016 - 2021
Figure 7-18: Global Liquid Biopsy - Forecast for Non-Cancer Application Market (Million US$), 2022 - 2030
Figure 8-1: Global Liquid Biopsy Oncology Application - Therapy Selection Market (Million US$), 2016 - 2021
Figure 8-2: Global Liquid Biopsy Oncology Application - Forecast for Therapy Selection Market (Million US$), 2022 - 2030
Figure 8-3: Global Liquid Biopsy Oncology Application - Treatment Monitoring Market (Million US$), 2016 - 2021
Figure 8-4: Global Liquid Biopsy Oncology Application - Forecast for Treatment Monitoring Market (Million US$), 2022 - 2030
Figure 8-5: Global Liquid Biopsy Oncology Application - Early Cancer Screening Market (Million US$), 2016 - 2021
Figure 8-6: Global Liquid Biopsy Oncology Application - Forecast for Early Cancer Screening Market (Million US$), 2022 - 2030
Figure 8-7: Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market (Million US$), 2016 - 2021
Figure 8-8: Global Liquid Biopsy Oncology Application - Forecast for Recurrence Monitoring Market (Million US$), 2022 - 2030
Figure 9-1: Global Liquid Biopsy - Reference Laboratories Market (Million US$), 2016 - 2021
Figure 9-2: Global Liquid Biopsy - Forecast for Reference Laboratories Market (Million US$), 2022 - 2030
Figure 9-3: Global Liquid Biopsy - Hospitals and Physician Laboratories Market (Million US$), 2016 - 2021
Figure 9-4: Global Liquid Biopsy - Forecast for Hospitals and Physician Laboratories Market (Million US$), 2022 - 2030
Figure 9-5: Global Liquid Biopsy - Academic and Research Centers Market (Million US$), 2016 - 2021
Figure 9-6: Global Liquid Biopsy - Forecast for Academic and Research Centers Market (Million US$), 2022 - 2030
Figure 9-7: Global Liquid Biopsy - Other End Users Market (Million US$), 2016 - 2021
Figure 9-8: Global Liquid Biopsy - Forecast for Other End Users Market (Million US$), 2022 - 2030
Figure 10-1: Global Liquid Biopsy - Blood Sample Market (Million US$), 2016 - 2021
Figure 10-2: Global Liquid Biopsy - Forecast for Blood Sample Market (Million US$), 2022 - 2030
Figure 10-3: Global Liquid Biopsy - Urine Sample Market (Million US$), 2016 - 2021
Figure 10-4: Global Liquid Biopsy - Forecast for Urine Sample Market (Million US$), 2022 - 2030
Figure 10-5: Global Liquid Biopsy - Other Fluids Sample Market (Million US$), 2016 - 2021
Figure 10-6: Global Liquid Biopsy - Forecast for Other Fluids Sample Market (Million US$), 2022 - 2030
Figure 11-1: North America - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 11-2: North America - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 11-3: Asia Pacific - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 11-4: Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 11-5: Europe - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 11-6: Europe - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 11-7: Latin America - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 11-8: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 11-9: Middle East & Africa - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 11-10: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-1: United States - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-2: United States - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-3: Canada - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-4: Canada - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-5: South Korea - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-6: South Korea - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-7: Japan - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-8: Japan - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-9: China - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-10: China - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-11: India - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-12: India - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-13: Australia - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-14: Australia - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-15: Rest of Asia Pacific - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-16: Rest of Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-17: Germany - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-18: Germany - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-19: France - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-20: France - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-21: United Kingdom - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-22: United Kingdom - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-23: Italy - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-24: Italy - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-25: Spain - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-26: Spain - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-27: Rest of Europe - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-28: Rest of Europe - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-29: UAE - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-30: UAE - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-31: Saudi Arabia - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-32: Saudi Arabia - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-33: Egypt - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-34: Egypt - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-35: Rest of Middle East & Africa - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-36: Rest of Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030
Figure 12-37: Latin America - Liquid Biopsy Market (Million US$), 2016 - 2021
Figure 12-38: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2022 - 2030

List of Tables:

Table 4-1: By Cancer Types - Liquid Biopsy Oncology Market Share (Percent), 2016 - 2021
Table 4-2: By Cancer Types - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2022 - 2030
Table 4-3: By Region - Liquid Biopsy Market Share (Percent), 2016 - 2021
Table 4-4: By Region - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
Table 4-5: By Country - Liquid Biopsy Market Share (Percent), 2016 - 2021
Table 4-6: By Country - Forecast for Liquid Biopsy Market Share (Percent), 2022 - 2030
Table 15-1: Clearbridge BioMedics - Distributors in EMEA and APAC Regions

  • Global C-Reactive Protein Test (CRP) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 09-Sep-2022        Price: US 5900 Onwards        Pages: 116
    C-reactive protein (CRP) is an annular (ring-shaped), pentameric protein found in blood plasma, whose levels rise in response to inflammation. C - Reactive Protein Test(CRP) is the C- reactive protein (CRP) assay kit which is used for research and for diagnostic. It can detect the C-reactive protein in human serum and plasma samples. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global C-Reactive Protein Test (CRP) market i......
  • Global C-Reactive Protein (Crp) Test Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 08-Sep-2022        Price: US 3450 Onwards        Pages: 110
    The report focuses on the C-Reactive Protein(Crp) Test market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream mark......
  • Global Hemostasis Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Sep-2022        Price: US 3450 Onwards        Pages: 104
    The report focuses on the Hemostasis market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, cust......
  • Global Blood Culture Test Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 06-Sep-2022        Price: US 5900 Onwards        Pages: 107
    Blood cultures are used to detect the presence of bacteria or fungi in the blood, to identify the type present, and to guide treatment. Testing is used to identify a blood infection (septicemia) that can lead to sepsis, a serious and life-threatening complication. Individuals with a suspected blood infection are often treated in intensive care units, so testing is often done in a hospital setting. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine......
  • Global Blood Culture Test Market Research Report 2022
    Published: 05-Sep-2022        Price: US 2900 Onwards        Pages: 94
    Blood Culture Test market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Blood Culture Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Instruments - Consumables - Others Segment by Application......
  • Global Vitamin D Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 31-Aug-2022        Price: US 5900 Onwards        Pages: 119
    Vitamin D is vital for strong bones. It also has important, emerging roles in immune function and cancer prevention. Deficiencies at any stage of life can have devastating consequences. Similarly, vitamin D toxicity resulting from overmedication can cause serious hyperkalemia. Vitamin D consists of two bioequivalent forms: Vitamin D2: obtained from vegetable sources (dietary sources, supplements) Vitamin D3: derived from both endogenous (synthesized from cholesterol through sun exp......
  • Liquid Biopsy Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 14-Aug-2022        Price: US 3500 Onwards        Pages: 99
    This report describes the global market size of Liquid Biopsy from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included s......
  • (Post-pandemic Era) - Global Immunohematology Market Segment Research Report 2022
    Published: 02-Aug-2022        Price: US 3350 Onwards        Pages: 95
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • Post-pandemic Era - Global Immunohematology Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
    Published: 02-Aug-2022        Price: US 4860 Onwards        Pages: 90
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs